SGHT TearCare gains first-only MGD indication for evaporative dry eye
SGHT says its TearCare is the first and only treatment indicated to improve meibomian gland function in patients with evaporative dry eye disease.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.